¥256 2.0 0.8%
Last Trade - 15/01/21
Market Cap | £28.8m |
Enterprise Value | £20.8m |
Revenue | £1.05m |
Position in Universe | 3259th / 3893 |
Feb 14 (Reuters)- CellSeed Inc. CONSOLIDATED FINANCIAL HIGHLIGHTS (in billions of yen unless specified) Year ended Year ended Year to NEXT Dec 31, 2019 Dec 31, 2018 Dec 31, 2020 YEAR LATEST YEAR-AGO COMPANY COMPANY RESULTS RESULTS FORECAST H1 FORECAST Sales 275 mln 1.03 310 mln 84 mln (-73.1 pct) (+12.4 pct) (-48.3 pct) Operating loss 780 mln 140 mln loss 1.02 loss 570 mln Recurring loss 786 mln 140 mln loss 1.02 loss 570 mln Net Net loss 782 mln 129 mln loss 1.02 loss 570 mln EPS loss 66.60 yen 11.35 yen loss 78.57 yen loss 43.91 yen EPS Diluted 11.27 yen Ann Div NIL NIL NIL -Q2 Div NIL NIL NIL -Q4 Div NIL NIL NIL NOTE - CellSeed Inc.. *Second Net profit row denotes profit attributable to owners ofthe parent To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=7776.T